Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging

[1]  M. Taupitz,et al.  High-resolution t2-weighted abdominal magnetic resonance imaging using respiratory triggering: impact of butylscopolamine on image quality , 2008, Acta radiologica.

[2]  R. Swindell,et al.  The value of hyoscine butylbromide in pelvic MRI. , 2007, Clinical radiology.

[3]  Johannes M Froehlich,et al.  Non-invasive measurement of small-bowel motility by MRI after abdominal surgery , 2007, Gut.

[4]  G. Tytgat.  Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. , 2007, Drugs.

[5]  Johannes M Froehlich,et al.  Small bowel motility assessment with magnetic resonance imaging , 2005, Journal of magnetic resonance imaging : JMRI.

[6]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[7]  D. Drucker,et al.  International Union of Pharmacology. XXXV. The Glucagon Receptor Family , 2003, Pharmacological Reviews.

[8]  L. Martí-Bonmatí,et al.  Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations , 2003, European Radiology.

[9]  Hansen Mb,et al.  Small intestinal manometry. , 2002 .

[10]  M. Hansen,et al.  Small intestinal manometry. , 2002, Physiological research.

[11]  D. Drucker,et al.  The Glucagon Receptor Family , 2000 .

[12]  J Silny,et al.  Multiple intraluminal electrical impedancometry for recording of upper gastrointestinal motility: current results and further implications , 1999, American Journal of Gastroenterology.

[13]  Michael Camilleri,et al.  Measurement of gastrointestinal motility in the GI laboratory. , 1998, Gastroenterology.

[14]  F. Sardanelli,et al.  Compared effect of a genetically engineered glucagon and hyoscine N-butylbromide on double-contrast barium meal study , 1998, European Radiology.

[15]  L. Martí-Bonmatí,et al.  Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs , 1996, Abdominal Imaging.

[16]  R. Kozak,et al.  Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon. , 1994, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[17]  T. Massoud,et al.  Dose reduction of hyoscine-N-butylbromide for double-contrast barium meal examinations--a prospective randomized study. , 1992, Clinical radiology.

[18]  M. Hunt.  Radiographic features in patients with pulmonary manifestations of the acquired immune deficiency syndrome , 1986 .

[19]  D. N. Huepscher,et al.  Action and side effects of small doses of buscopan in gastroduodenal radiography. A prospective study in 300 patients. , 1984, Diagnostic imaging in clinical medicine.